Randomized Placebo-Controlled Trial of 2,3-Dimercapto-1-propanesulfonate (DMPS) in Therapy of Chronic Arsenicosis Due to Drinking Arsenic-Contaminated Water
- 1 January 2001
- journal article
- clinical trial
- Published by Taylor & Francis in Journal of Toxicology: Clinical Toxicology
- Vol. 39 (7) , 665-674
- https://doi.org/10.1081/clt-100108507
Abstract
(2001). Randomized Placebo-Controlled Trial of 2,3-Dimercapto-1-propanesulfonate (DMPS) in Therapy of Chronic Arsenicosis Due to Drinking Arsenic-Contaminated Water. Journal of Toxicology: Clinical Toxicology: Vol. 39, No. 7, pp. 665-674. doi: 10.1081/CLT-100108507Keywords
This publication has 24 references indexed in Scilit:
- Acute arsenic poisoning: absence of polyneuropathy after treatment with 2,3-dimercaptopropanesulphonate (DMPS).Journal of Neurology, Neurosurgery & Psychiatry, 1994
- Metal‐induced developmental toxicity in mammals: A reviewJournal of Toxicology and Environmental Health, 1994
- Efficacy of Dimercapto Chelatin Agents for the Treatment of Poisoning by Percutaneously Applied Dichloro(2-chlorovinyl)arsine in RabbitsHuman & Experimental Toxicology, 1993
- Semiempirical self-consistent field (CNDO) calculations of arsenical-antidote adductsChemical Research in Toxicology, 1992
- Efficacy of various dithiol compounds in acute As2O3 poisoning in miceArchives of Toxicology, 1990
- Two‐dimensional NMR studies of arsenical‐sulfhydryl adductsMagnetic Resonance in Chemistry, 1989
- A hypothesis for the selection of chelate antidotes for toxic metalsMedical Hypotheses, 1982
- Interactions of the chelating agent 2,3-dimercaptopropane-1-sulfonate with red blood cells in vitro. II. effects on metalloproteinsChemico-Biological Interactions, 1982
- Interactions of the chelating agent 2,3-dimercapto-propane-1-sulfonate with red blood cells in vitro. I. Evidence for carrier mediated transportChemico-Biological Interactions, 1982
- THE RETENTION OF ARSENIC IN THE LATE CUTANEOUS COMPLICATIONS OF ITS ADMINISTRATION.British Journal of Dermatology, 1958